Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply

Ikuo Hirano; Evan S. Dellon; Sandeep K. Gupta; David A. Katzka; Margaret H. Collins; Abigail M. Wojtowicz; Brian Terreri; Wenwen Zhang; Mena Boules; Siddharth Bhatia; Nirav K. Desai

doi:10.1111/apt.17476

Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply

Ikuo Hirano^*, Evan S. Dellon, Sandeep K. Gupta, David A. Katzka, Margaret H. Collins, Abigail M. Wojtowicz, Brian Terreri, Wenwen Zhang, Mena Boules, Siddharth Bhatia, Nirav K. Desai

^*Corresponding author for this work

Medicine, Gastroenterology Division

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1163-1165
Number of pages	3
Journal	Alimentary Pharmacology and Therapeutics
Volume	57
Issue number	10
DOIs	https://doi.org/10.1111/apt.17476
State	Published - May 2023

Funding

: Medical writing support was provided by Joanna L Donnelly, PhD, of PharmaGenesis London, London, UK, and funded by Takeda Pharmaceuticals USA, Inc. The authors' declarations of personal and financial interests are unchanged from those in the original article. Declaration of personal interests 2

ASJC Scopus subject areas

Gastroenterology
Pharmacology (medical)
Hepatology

Access to Document

10.1111/apt.17476

Cite this

Hirano, I., Dellon, E. S., Gupta, S. K., Katzka, D. A., Collins, M. H., Wojtowicz, A. M., Terreri, B., Zhang, W., Boules, M., Bhatia, S., & Desai, N. K. (2023). Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply. Alimentary Pharmacology and Therapeutics, 57(10), 1163-1165. https://doi.org/10.1111/apt.17476

@article{2714cceb7301417d85c3c4f7ecd9656e,

title = "Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply",

author = "Ikuo Hirano and Dellon, {Evan S.} and Gupta, {Sandeep K.} and Katzka, {David A.} and Collins, {Margaret H.} and Wojtowicz, {Abigail M.} and Brian Terreri and Wenwen Zhang and Mena Boules and Siddharth Bhatia and Desai, {Nirav K.}",

note = "Funding Information: : Medical writing support was provided by Joanna L Donnelly, PhD, of PharmaGenesis London, London, UK, and funded by Takeda Pharmaceuticals USA, Inc. The authors' declarations of personal and financial interests are unchanged from those in the original article. Declaration of personal interests 2 ",

year = "2023",

month = may,

doi = "10.1111/apt.17476",

language = "English (US)",

volume = "57",

pages = "1163--1165",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "Wiley-Blackwell",

number = "10",

}

Hirano, I, Dellon, ES, Gupta, SK, Katzka, DA, Collins, MH, Wojtowicz, AM, Terreri, B, Zhang, W, Boules, M, Bhatia, S & Desai, NK 2023, 'Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply', Alimentary Pharmacology and Therapeutics, vol. 57, no. 10, pp. 1163-1165. https://doi.org/10.1111/apt.17476

TY - JOUR

T1 - Editorial

T2 - safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply

AU - Hirano, Ikuo

AU - Dellon, Evan S.

AU - Gupta, Sandeep K.

AU - Katzka, David A.

AU - Collins, Margaret H.

AU - Wojtowicz, Abigail M.

AU - Terreri, Brian

AU - Zhang, Wenwen

AU - Boules, Mena

AU - Bhatia, Siddharth

AU - Desai, Nirav K.

N1 - Funding Information: : Medical writing support was provided by Joanna L Donnelly, PhD, of PharmaGenesis London, London, UK, and funded by Takeda Pharmaceuticals USA, Inc. The authors' declarations of personal and financial interests are unchanged from those in the original article. Declaration of personal interests 2

PY - 2023/5

Y1 - 2023/5

UR - http://www.scopus.com/inward/record.url?scp=85153687281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85153687281&partnerID=8YFLogxK

U2 - 10.1111/apt.17476

DO - 10.1111/apt.17476

M3 - Editorial

C2 - 37094318

AN - SCOPUS:85153687281

SN - 0269-2813

VL - 57

SP - 1163

EP - 1165

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 10

ER -

Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this